Fishing for the origins of cancer

Genes and Development

Volumn 21, Issue 11, 2007, Pages 1275-1279

  Merlino, Glenn ^a   Khanna, Chand ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN;

CANCER; CARCINOGENESIS; CELL DIVISION; GENE DISRUPTION; GENE MUTATION; GENE TRANSLOCATION; GENETIC SCREENING; HUMAN; LEUKEMIA; MUTAGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RHABDOMYOSARCOMA; SARCOMA; TUMOR CELL; ZEBRA FISH;

ANIMALS; DISEASE MODELS, ANIMAL; RHABDOMYOSARCOMA, EMBRYONAL; ZEBRAFISH;

EID: 34249905193     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1563707     Document Type: Review

References (37)

1. Barr, F.G. 1998. Translocations, cancer and the puzzle of specificity. Nat. Genet. 19: 121-124.
2. Berghmans, S., Jette, C., Langenau, D., Hsu, K., Stewart, R., Look, T., and Kanki, J.P. 2005. Making waves in cancer research: New models in the zebrafish. Biotechniques 39: 227-237.
3. Brown, K., Strathdee, D., Bryson, S., Lambie, W., and Balmain, A. 1998. The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted. Curr. Biol. 8: 516-524.
4. Castillero-Trejo, Y., Eliazer, S., Xiang, L., Richardson, J.A., and Ilaria, R.L. 2005. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells results in EWS/FLI-1-dependent, Ewing sarcoma-like tumors. Cancer Res. 65: 8698-8705.
5. Chen, Y., Takita, J., Hiwatari, M., Igarashi, T., Hanada, R., Kikuchi, A., Hongo, T., Taki, T., Ogasawara, M., Shimada, A., et al. 2006. Mutations of the PTPN11 and RAS genes in rhabdomyosarcoma and pediatric hematological malignancies. Genes Chromosomes Cancer 45: 583-591.
6. Crans, H.N. and Sakamoto, K.M. 2001. Transcription factors and translocations in lymphoid and myeloid leukemia. Leukemia 15: 313-331.
7. Deneen, B. and Denny, C.T. 2001. Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation. Oncogene 20: 6731-6741.
8. Fleischmann, A., Jochum, W., Eferl, R., Witowsky, J., and Wagner, E.F. 2003. Rhabdomyosarcoma development in mice lacking Trp53 and Fos: Tumor suppression by the Fos protooncogene. Cancer Cell 4: 477-482.
9. Haldar, M., Hancock, J.D., Coffin, C.M., Lessnick, S.L., and Capecchi, M.R. 2007. A conditional mouse model of synovial sarcoma: Insights into a myogenic origin. Cancer Cell 11: 375-388.
10. Helman, L.J. and Meltzer, P. 2003. Mechanisms of sarcoma development. Nat. Rev. Cancer 3: 685-694.
11. Iacobuzio-Donahue, C.A., Maitra, A., Olsen, M., Lowe, A.W., van Heek, N.T., Rosty, C., Walter, K., Sato, N., Parker, A., Ashfaq, R., et al. 2003. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am. J. Pathol. 162: 1151-1162.
12. Keller, C., Arenkiel, B.R., Coffin, C.M., El-Bardeesy, N., DePinho, R.A., and Capecchi, M.R. 2004. Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: Cooperativity of Ink4a/ARF and Trp53 loss of function. Genes & Dev. 18: 2614-2626.
13. Kim, C.F., Jackson, E.L., Woolfenden, A.E., Lawrence, S., Babar, I., Vogel, S., Crowley, D., Bronson, R.T., and Jacks, T. 2005. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121: 823-835.
14. Lagutina, I., Conway, S.J., Sublett, J., and Grosveld, G.C. 2002. Pax3-FKHR knock-in mice show developmental aberrations but do not develop tumors. Mol. Cell. Biol. 22: 7204-7216.
15. Lam, S.H., Wu, Y.L., Vega, V.B., Miller, L.D., Spitsbergen, J., Tong, Y., Zhan, H., Govindarajan, K.R., Lee, S., Mathavan, S., et al. 2006. Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Nat. Biotechnol. 24: 73-75.
16. Langenau, D.M., Feng, H., Berghmans, S., Kanki, J.P., Kutok, J.L., and Look, A.T. 2005. Cre/lox-regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. 102: 6068-6073.
17. Langenau, D.M., Keefe, M.D., Storer, N.Y., Guyon, J.R., Kutok, J.L., Le, X., Goessling, W., Neuberg, D.S., Kunkel, L.M., and Zon, L.I. 2007. Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes & Dev. (this issue) doi: 10.1101/gad.1545007.
18. Lessnick, S.L., Dacwag, C.S., and Golub, T.R. 2002. The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts. Cancer Cell 1: 393-401.
19. Mackall, C.L., Meltzer, P.S., and Helman, L.J. 2002. Focus on sarcomas. Cancer Cell 2: 175-178.
20. Meletis, K., Wirta, V., Hede, S.M., Nister, M., Lundeberg, J., and Frisen, J. 2006. p53 suppresses the self-renewal of adult neural stem cells. Development 133: 363-369.
21. Mercado, G.E. and Barr, F.G. 2007. Fusions involving PAX and FOX genes in the molecular pathogenesis of alveolar rhabdomyosarcoma: Recent advances. Curr. Mol. Med. 7: 47-61.
22. Merlino, G. and Helman, L.J. 1999. Rhabdomyosarcoma - Working out the pathways. Oncogene 18: 5340-5348.
23. Nanni, P., Nicoletti, G., De Giovanni, C., Croci, S., Astolfi, A., Landuzzi, L., Di Carlo, E., Iezzi, M., Musiani, P., and Lollini, P.L. 2003. Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. Cancer Res. 63: 2728-2732.
24. Pan, X., Wan, H., Chia, W., Tong, Y., and Gong, Z. 2005. Demonstration of site-directed recombination in transgenic zebrafish using the Cre/loxP system. Transgenic Res. 14: 217-223.
25. Ramaswamy, S., Tamayo, P., Rifkin, R., Mukherjee, S., Yeang, C.H., Angelo, M., Ladd, C., Reich, M., Latulippe, E., Mesirov, J.P., et al. 2001. Multiclass cancer diagnosis using tumor gene expression signatures. Proc. Natl. Acad. Sci. 98: 15149-15154.
26. Reya, T., Morrison, S.J., Clarke, M.F., and Weissman, I.L. 2001. Stem cells, cancer, and cancer stem cells. Nature 414: 105-111.
27. Riggi, N., Cironi, L., Provero, P., Suvà, M.L., Kaloulis, K., Garcia-Echeverria, C., Hoffmann, F., Trumpp, A., and Stamenkovic, I. 2005. Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res. 65: 11459-11468.
28. Riggi, N., Cironi, L., Provero, P., Suvà, M., Stehle, J., Baumer, K., Guillou, L., and Stamenkovic, I. 2006. Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma. Cancer Res. 66: 7016-7023.
29. Schneider, M.D. and Olson, E.N. 1988. Control of myogenic differentiation by cellular oncogenes. Mol. Neurobiol. 2: 1-39.
30. Sharp, R., Recio, J.A., Jhappan, C., Otsuka, T., Liu, S., Yu, Y., Liu, W., Anver, M., Navid, F., Helman, L.J., et al. 2002. Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis. Nat. Med. 8: 1276-1280.
31. Stern, H.M. and Zon, L.I. 2003. Cancer genetics and drug discovery in the zebrafish. Nat. Rev. Cancer 3: 533-539.
32. Stratton, M.R., Fisher, C., Gusterson, B.A., and Cooper, C.S. 1989. Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction. Cancer Res. 49: 6324-6327.
33. Sweet-Cordero, A., Mukherjee, S., Subramanian, A., You, H., Roix, J.J., Ladd-Acosta, C., Mesirov, J., Golub, T.R., and Jacks, T. 2005. An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis. Nat. Genet. 37: 48-55.
34. Tolar, J., Nauta, A.J., Osborn, M.J., Panoskaltsis Mortari, A., McElmurry, R.T., Bell, S., Xia, L., Zhou, N., Riddle, M., Schroeder, T.M., et al. 2007. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 25: 371-379.
35. Tsumura, H., Yoshida, T., Saito, H., Imanaka-Yoshida, K., and Suzuki, N. 2006. Cooperation of oncogenic K-ras and p53 deficiency in pleomorphic rhabdomyosarcoma development in adult mice. Oncogene 25: 7673-7679.
36. Wachtel, M., Dettling, M., Koscielniak, E., Stegmaier, S., Treuner, J., Simon-Klingenstein, K., Buhlmann, P., Niggli, F.K., and Schafer, B.W. 2004. Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1. Cancer Res. 64: 5539-5545.
37. Weijzen, S., Rizzo, P., Braid, M., Vaishnav, R., Jonkheer, S.M., Zlobin, A., Osborne, B.A., Gottipati, S., Aster, J.C., Hahn, W.C., et al. 2002. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat. Med. 8: 979-986.